Across TCGA pan-cancer cohorts, MOG Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MOG data layer compared with 19 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MOG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MOG expression acts as an unfavorable survival marker.

LUAD and LIHC are the cancer types where MOG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.171	0.669	.001	13	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MOG tumor-vs-normal RNA expression · all MOG data types